Subscribe to RSS - The Braff Group

The Braff Group

COVID-19 and HME M&A

Thursday, May 14, 2020

I caught up with Brad Smith, managing director and partner at Vertess, recently and he said the mergers and acquisition market for HME has been “a wild rollercoaster ride” amid the coronavirus pandemic.

Are we headed for another 2012?

Wednesday, November 28, 2018

“We believe we’re on the cusp of another 2012,” said Dexter Braff during a webcast today on the M&A outlook for HME.

What happened in 2012?


Buckle up, 2018 is going to be ‘huge’ for M&A, analysts say


YARMOUTH, Maine – Expect to see large regional HME players get bigger in the year ahead as they look to increase their market share, say M&A analysts.

Good signs? Tell me more

Friday, January 5, 2018

The print issues of HME News are on their way to your mailboxes (if not already there), but I wanted to call your attention to page 22. Here you will find, as you do every month, The Braff Group M&A Insider.


M&A: Buyer appetite for HME improves


YARMOUTH, Maine – After a slow first quarter, buyer appetites for HME businesses are picking up, say M&A analysts.

M&A market holds steady in 2016

Manufacturers pulled out their checkbooks, and niche providers thrived

YARMOUTH, Maine – The pace of acquisitions slowed down a bit in 2016, but overall it was a decent year for buyers, say analysts.

In brief: A&D, PharMerica close out year with buys


SAN JOSE, Calif. – A&D Company has entered into a definitive agreement to buy the necessary business assets of Toronto-based Auto Control Medical. The deal allows A&D to expand its product range and application experience across the Americas.

PharMerica closes year with two buys


LOUISVILLE, Ky. – Amerita, a subsidiary of PharMerica, a national provider of institutional and specialty pharmacy services, has acquired Alternacare Infusion Pharmacy, an Olathe, Kan.-based specialty home infusion provider.

Mergers & Acquisitions: Perform due diligence

Q. What are the primary reasons why an acquisition doesn’t close?

A. In mergers and acquisitions, many deals don’t actually close for a variety of reasons.

Mergers & Acquisitions: Uncover the best deal

Q. When it comes to making an offer to buy an HME provider, how do buyers determine the price?

A. The primary theoretical components are definitely in play—income, growth, and risk. The lower the go-forward risk and the greater the go-forward growth opportunity, the greater the multiple of income a buyer is likely to offer a provider.